Overview
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
Status:
Completed
Completed
Trial end date:
2003-12-01
2003-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alcon Research
Criteria
Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not
worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.